Physician profile
Riya Thenayan
NPI 1124499850
$2,113.21
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $571 · 2022: $461 · 2023: $81.86 · 2024: $891 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,081.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $775.23 | 2024 | Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $410.32 | 2021 | |
| Novo Nordisk INC | $362.68 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $116.15 | 2024 | Inpefa |
| Abbott Laboratories | $113.08 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $81.86 | 2023 | Amvuttra |
| Merck Sharp & Dohme LLC | $56.14 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $46.16 | 2021 | |
| Medtronic, INC. | $45.83 | 2025 | Micra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.53 | 2021 | |
| Inspire Medical Systems, INC. | $41.40 | 2025 | Inspire |
| Philips North America LLC | $20.83 | 2025 | Bridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Riya Thenayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.